Urinary cytokines for assessing inflammation in HIV-associated wasting

Cytokine

Volumn 13, Issue 5, 2001, Pages 305-313

  Rivera, Seth ^a   Sattler, Fred R ^a   Boyd, Holly ^a   Auffenberg, Troy ^b   Nakao, Susie ^a   Moldawer, Lyle L ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

HIV wasting syndrome; Interleukin 1; Interleukin 6; Receptors; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALE; PRIORITY JOURNAL; URINALYSIS; WASTING SYNDROME; WEIGHT REDUCTION;

EID: 0035819765     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0830     Document Type: Article

References (37)

1. Energy expenditure and wasting in human immunodeficiency virus infection
2. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS
3. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection
4. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
5. Resting energy expenditure is increased in stable, malnourished HIV-infected patients
6. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage
7. Energy expenditure in human immunodeficiency virus infection
8. Determinants of metabolic rate and body composition in adults with HIV infection
9. Altered cytokine production in patients following institution of highly active antiretroviral therapy
10. The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: Correlation between plasma HIV-1 RNA and proinflammatory cytokine levels
11. Weight loss, the gut and the inflammatory response in AIDS patients
12. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss
13. Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states
14. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection
15. Metabolic disturbances in AIDS: Role of circulating interferon alpha (IFNa) and tumor necrosis factor (TNF) in the hypertriglyceridemia of AIDS
16. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
17. Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HiV infection
18. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type I infection
19. Serum levels of tumor necrosis factor-a (TNFa) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical immunologic, and virologic parameters
20. Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients
21. Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection
22. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients
23. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo
24. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
25. Interleukin-6 and the acute phase response
26. IL-6 and the acute phase reaction
27. Excretion of IL-6 by astronauts during space flight
28. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans
29. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist
30. Interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist
31. HIV predominantly induces IL-1 receptor antagonist over IL-1 synthesis in human primary monocytes
32. Levels of HIV RNA are quantitatively related to prior weight loss in HIV-associated wasting
33. Predictive markers of HIV-related weight loss and determination of differences between populations with weight loss stratified by opportunistic processes
34. Negative transcriptional regulation by nuclear receptors
35. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids
36. Tumor necrosis factor receptor expression and signal transduction in HIV-I infected cells
37. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease